Clinical trial

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

NCT07595042

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Isoniazid Normalized identity: isoniazidView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Rifampin Normalized identity: rifampinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pyrazinamide Normalized identity: pyrazinamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ethambutol Normalized identity: ethambutolView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Rifapentine Normalized identity: rifapentineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Moxifloxacin Normalized identity: moxifloxacinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-10-30

PhasePHASE2

Conditions

Tuberculosisverified · MONDO: tuberculosis

Interventions

IsoniazidDRUG · verified · RxNorm: isoniazid

RifampinDRUG · verified · RxNorm: rifampin

PyrazinamideDRUG · verified · RxNorm: pyrazinamide

EthambutolDRUG · verified · RxNorm: ethambutol

RifapentineDRUG · verified · RxNorm: rifapentine

MoxifloxacinDRUG · verified · RxNorm: moxifloxacin

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

ViiV Healthcarecollaborator

Mapped research locations

LimaPeru3 Buenos AiresArgentina1 BangkokThailand1 Mexico CityMexico1 Rio de JaneiroBrazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07595042 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.